Analyst Ratings for Arch Therapeutics (ARTH) [Buys]
Avg. $ Target:
N/A
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/14/2018 | IFS Securities | N/A | Downgrade | Outperform (Strong Buy) |
1.85 (N/A) |
0.31 (1.18) |
280.65% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/14/2018 | IFS Securities | N/A | Downgrade | Outperform (Strong Buy) |
1.85 (N/A) |
0.31 (1.18) |
280.65% | Details |
